|




Promising new Alzheimer's drugs may be less effective for Black patients

The two drugs — Leqembi and donanemab — are the first to offer real hope of slowing the fatal disease for the 6.5 million Americans living with ...


View article...


Los 8 artículos más leídos de los últimos 30 días